By NZPA
|
Thursday 24th October 2002 |
Text too small? |
Nuplex is negotiating the sale of Medihold International 3 Pty Ltd and Daniels Sharpsmart Australia Pty Ltd, a joint venture handling sharp instruments, to Australian medical waste processor Steriocorp Ltd.
The deal is subject to due diligence and legalities.
"Stericorp have advised Nuplex that they are well advanced with their due diligence process," Nuplex said.
Nuplex bought Medihold and Daniels almost two years ago but Medihold's troubles almost immediately became clear when it lost an important waste management contract with New South Wales public hospitals.
As a consequence Nuplex wrote down $11.9 million on Medihold last year , blaming incomplete information during the purchase process.
The writedown -- nearly half Medihold's purchase price -- forced Nuplex to restate its June 2001 year profit down to $1.3 million from the $13.2 million previously anticipated.
"I guess you could say it lost our interest and was becoming a bit of a management diversion," Nuplex chairman Fred Holland told NZPA.
Medihold had picked up some business since losing the hospital contracts but "it was a long road ahead of us".
A final price had not been negotiated.
Mr Holland said that Nuplex would continue to use the New Zealand part of the sharps recycling venture which is part of its New Zealand Environmental Services arm.
No comments yet
Nuplex targets half billion dollar Asian sales within five years
Nuplex FY profit drops 31 percent on weak ANZ, EMEA markets, writedowns
Nuplex cuts FY guidance again as Australian manufacturing splutters; stock drops
Nuplex 1H profit misses forecasts; annual guidance cut on strong kiwi, weak trading conditions
Nuplex looks at imputing future dividends, flags increased earnings
Nuplex plans restructuring in Australia, NZ to cut 2013 profit
Nuplex FY profit falls, guidance met
Nuplex raises US$105M in US private placement
Nuplex sees full-year earnings at bottom of range
Nuplex 1H profit drops 23% on Australasian weakness
